NO984964L - Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og ved depresjon - Google Patents

Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og ved depresjon

Info

Publication number
NO984964L
NO984964L NO984964A NO984964A NO984964L NO 984964 L NO984964 L NO 984964L NO 984964 A NO984964 A NO 984964A NO 984964 A NO984964 A NO 984964A NO 984964 L NO984964 L NO 984964L
Authority
NO
Norway
Prior art keywords
brain
depression
treatment
functional disorders
phosphonic esters
Prior art date
Application number
NO984964A
Other languages
English (en)
Norwegian (no)
Other versions
NO984964D0 (no
Inventor
Fritz Maurer
Bernard Schmidt
Stephan Lensky
Franz-Josef Van Der Staay
Richard Joseph Fanelli
David Ross Britelli
Original Assignee
Troponwerke Gmbh & Co Kg
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co Kg, Bayer Ag filed Critical Troponwerke Gmbh & Co Kg
Publication of NO984964D0 publication Critical patent/NO984964D0/no
Publication of NO984964L publication Critical patent/NO984964L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO984964A 1996-04-25 1998-10-23 Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og ved depresjon NO984964L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19616471A DE19616471A1 (de) 1996-04-25 1996-04-25 Phosponsäureester zur Behandlung von Hirnleistungsstörungen und Depressionen
PCT/US1997/006469 WO1997039756A1 (en) 1996-04-25 1997-04-17 Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression

Publications (2)

Publication Number Publication Date
NO984964D0 NO984964D0 (no) 1998-10-23
NO984964L true NO984964L (no) 1998-12-22

Family

ID=7792381

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984964A NO984964L (no) 1996-04-25 1998-10-23 Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og ved depresjon

Country Status (19)

Country Link
EP (1) EP0896540A1 (es)
JP (1) JP2000510455A (es)
KR (1) KR20000010611A (es)
AR (1) AR006870A1 (es)
AU (1) AU2462397A (es)
BG (1) BG102864A (es)
BR (1) BR9709300A (es)
CA (1) CA2252567A1 (es)
CZ (1) CZ343498A3 (es)
DE (1) DE19616471A1 (es)
HU (1) HUP9903366A3 (es)
ID (1) ID16678A (es)
IL (1) IL126698A0 (es)
NO (1) NO984964L (es)
PL (1) PL333464A1 (es)
SK (1) SK146398A3 (es)
TR (1) TR199802137T2 (es)
WO (1) WO1997039756A1 (es)
ZA (1) ZA973538B (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1078370B (de) * 1958-09-16 1960-03-24 Norddeutsche Affinerie Schaedlingsbekaempfungsmittel
US3069312A (en) * 1960-09-28 1962-12-18 California Research Corp N-substituted dimethyl 1-carbamoyloxy-2, 2, 2-trichloroethyl phosphonates as insecticidal compositions
NL292791A (es) * 1962-05-16 1900-01-01
DE1193044B (de) * 1963-08-05 1965-05-20 Bayer Ag Verfahren zur Herstellung phosphorylierter Urethane
DE2512375A1 (de) * 1975-03-21 1976-09-30 Bayer Ag 1-hydroxy-2,2,2-trichloraethan- thionophosphonsaeuredialkylester, verfahren zu ihrer herstellung sowie ihre verwendung als insektizide
US4950658A (en) * 1988-12-06 1990-08-21 Board Of Trustees Of Southern Illinois Univ. Method of medical treatment of Alzheimer's disease

Also Published As

Publication number Publication date
ID16678A (id) 1997-10-30
SK146398A3 (en) 1999-06-11
CZ343498A3 (cs) 1999-02-17
PL333464A1 (en) 1999-12-20
AR006870A1 (es) 1999-09-29
BG102864A (en) 1999-09-30
HUP9903366A3 (en) 2000-08-28
WO1997039756A1 (en) 1997-10-30
HUP9903366A2 (en) 2000-07-28
TR199802137T2 (xx) 1999-02-22
DE19616471A1 (de) 1997-10-30
NO984964D0 (no) 1998-10-23
BR9709300A (pt) 1999-08-10
EP0896540A1 (en) 1999-02-17
AU2462397A (en) 1997-11-12
ZA973538B (en) 1997-11-18
CA2252567A1 (en) 1997-10-30
IL126698A0 (en) 1999-08-17
JP2000510455A (ja) 2000-08-15
KR20000010611A (ko) 2000-02-25

Similar Documents

Publication Publication Date Title
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
HUP9800033A3 (en) Compositions for the treatment of dermatological disorders and methods for their use
DE69722426D1 (de) Isobutylgaba und dessen derivate zur schmerzbehandlung
CA2264750A1 (en) Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
DE69627153D1 (de) Zusammensetzungen zur erzielung von analgesie und zur hemmung der progression neuropathischer schmerzerkrankungen
DE69534908D1 (de) Verwendung von statin zur behandlung von hauterkrankungen
FI950909A (fi) Rasvahappojohdannaisia
AU7222598A (en) Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
DE69519602D1 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
NO984964L (no) Anvendelse av fosfonsyreestere for behandling av funksjonelle forstyrrelser i hjernen og ved depresjon
NZ324615A (en) Method for treating autism using olanzapine
DE69720064D1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
DE59813022D1 (de) Verwendung von estern der cis-6-hexadecensäure zur behandlung von psoriasis, allergien und autoimmunerkrankungen sowie bei trockener und empfindlicher haut
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
PT828483E (pt) Utilizacao de derivados de tropolona como inibidores da enzima inositol monofosfatase
MXPA02004704A (es) Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.
AU9162298A (en) Use of cyclic phosphonic acid esters for the treatment of impaired cerebral function and depression
UA29506C2 (uk) Лікувально-косметичний засіб "фіто-пелоїд"
AU9260198A (en) Use of cycloalcane-phosphonic acid esters for treating mental disorders and depressions
EP1418167A3 (en) Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
ID16159A (id) Komposisi dan metode untuk mengobati gangguan pernafasan

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application